• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS SYMBOTEX; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS SYMBOTEX; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number SYM1510
Device Problems Material Deformation (2976); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Abdominal Pain (1685); Abscess (1690); Adhesion(s) (1695); Bacterial Infection (1735); Purulent Discharge (1812); Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Inflammation (1932); Pain (1994); Seroma (2069); Hernia (2240); Ascites (2596); Fluid Discharge (2686); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after implant, the patient experienced mesh protruding through hernia, recurrence, adhesions, infected mesh, mesh was exposed, pus, fascial dehiscence, abscess, discharge, seroma, loculated fluid collection with intrinsic air, inflammation, (b)(6), and blood in abdomen.Post-operative patient treatment included removal of mesh, hernia repair with mesh, adhesions taken down, removal of mesh, debridement of dehiscence, drainage of abscess, aspiration of seroma, debridement of subcutaneous tissue and fascia, admission to hospital, and application of negative pressure wound therapy.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after implant, the patient experienced mesh protruding through hernia, pain, abdominal pain, recurrence, adhesions, infected mesh, mesh was exposed, pus, fascial dehiscence, abscess, discharge, seroma, loculated fluid collection with intrinsic air, inflammation, staphylococcus aureus, and blood in abdomen.Post-operative patient treatment included removal of mesh, hernia repair with mesh, adhesions taken down, removal of mesh, debridement of dehiscence, drainage of abscess, aspiration of seroma, debridement of subcutaneous tissue and fascia, admission to hospital, ct-scan, mri, and application of negative pressure wound therapy.Relevant tests/laboratory data: (b)(6) 2018: abdominal scan (incomplete note, unclear if ct scan or mri) showed loculated fluid collection with intrinsic air and surrounding inflammation at the midline supraumbilical ventral abdominal wall deep subcutaneous tissue, highly concerning for focal abscess.Unrelated findings of colonic diverticulosis, small fat-containing bilateral inguinal hernias (b)(6) 2018: deep abscess culture + for staphylococcus aureus.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYMBOTEX
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
justin ellis
60 middletown ave.
8200 coral sea st ne
mounds view,mn, CT 55112
7635265677
MDR Report Key11753671
MDR Text Key248217916
Report Number9615742-2021-00934
Device Sequence Number1
Product Code FTL
UDI-Device Identifier10884521190375
UDI-Public10884521190375
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142908
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 01/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2022
Device Model NumberSYM1510
Device Catalogue NumberSYM1510
Device Lot NumberPRG1026X
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/14/2021
Initial Date FDA Received04/30/2021
Supplement Dates Manufacturer Received01/10/2024
Supplement Dates FDA Received01/12/2024
Date Device Manufactured11/03/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient SexMale
Patient Weight149 KG
-
-